Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 7, 2004, Pages 855-859

  Lee, Todd A ^a   Weiss, Kevin B ^b  

^a HINES VA HOSPITAL   (United States)

^b NONE

Author keywords

Chronic obstructive pulmonary disease; Fractures; Inhaled corticosteroids; Nested case control studies; Pharmacoepidemiology

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BONE DISEASE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; FRACTURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO;

EID: 1642447735     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200307-926oc     Document Type: Article

References (29)

1. Roche N, Lepage T, Bourcereau J, Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001;18:903-908.
2. Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel. The pharmacological management of chronic obstructive pulmonary disease. Washington, DC: Veterans Health Administration, Department of Veterans Affairs; 2002. PBM-MAP Publication No. 02-0012.
3. Clinical Practice Guideline Working Group. Management of chronic obstructive pulmonary disease. Washington, DC: Veterans Health Administration, Department of Veterans Affairs and Health Affairs, Department of Defense; 1999. Office of Quality and Performance Publication No. 10Q-CPG/COPD-00.
4. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1995;152:S77-S120.
5. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-1276.
6. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-1420.
7. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S1-S28.
8. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15: 993-1000.
9. Woodcock A. Effects of inhaled corticosteroids on bone density and metabolism. J Allergy Clin Immunol 1998;101:S456-S459.
10. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002;166:1563-1566.
11. van Staa TP, Leufkens HG, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 2001;16:581-588.
12. Lau E, Mamdani M, Tu K. Inhaled or systemic corticosteroids and the risk of hospitalization for hip fracture among elderly women. Am J Med 2003;114:142-145.
13. Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004;169:83-88.
14. Biskobing DM. COPD and osteoporosis. Chest 2002;121:609-620.
15. Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, Ciappi G, Pistelli R. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000;94:1079-1084.
16. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116:1616-1624.
17. Lee TA, Bartle B, Xu J, Davis KJ, Weiss KB. The association between inhaled corticosteroid use and fractures in veterans with chronic obstructive pulmonary disease [abstract]. Chest 2003;124:166S.
18. Lee TA, Bartle B, Xu J, Davis KJ, Weiss KB. The risk of fractures associated with inhaled corticosteroid use in patients with COPD [abstract]. US COPD Coalition National Conference 2003;1186.
19. Kelly HW. Comparison of inhaled corticosteroids. Ann Pharmacother 1998;32:220-232.
20. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1989.
21. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000;39:1383-1389.
22. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777-787.
23. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-282.
24. Manolagas SC. Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res 2000;15:1001-1005.
25. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-579.
26. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105:1722-1727.
27. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001;345:941-947.
28. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease: The Lung Health Study Research Group. N Engl J Med 2000;343:1902-1909.
29. Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux P-O, McDonell MB, Au DH. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death. Am J Respir Crit Care Med 2003;168:1488-1494.